Treatment of total hyphema with relatively low-dose tissue plasminogen activator

Ophthalmic Surgery and Lasers

Volumn 29, Issue 9, 1998, Pages 762-766

  Kim, Min Ho ^a   Koo, Tae Hyung ^a   Sah, Woo Jin ^a   Chung, Sang Moon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; CASE REPORT; DRUG EFFICACY; EYE INJURY; EYE SURGERY; HUMAN; HYPHEMA; INJECTION SITE; INTRAOCULAR PRESSURE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCHOOL CHILD; SLIT LAMP; VITREOUS HEMORRHAGE;

ADULT; AGED; ANTERIOR CHAMBER; CATARACT EXTRACTION; CHILD; DIABETES COMPLICATIONS; EYE INJURIES; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; HYPHEMA; INJECTIONS; MALE; POSTOPERATIVE COMPLICATIONS; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR; VISUAL ACUITY; VITRECTOMY; WOUNDS, NONPENETRATING;

EID: 0031664418     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Jaffe GJ, Lewis H, Han DP, Williams GA, Abrams GW. Treatment of post vitrectomy fibrin pupillary block with tissue plasminogen activator. Am J Ophthalmol. 1989;108:170-175.
2. Williams DF, Bennett SR, Abrams GW, et al. Low-dose intraocular tissue plasminogen activator for treatment of postvitrectomy fibrin formation. Am J Ophthalmol. 1990;109:606-607.
3. Tripathi RC, Tripathi BJ, Park JK, et al. Intracameral tissue plasminogen activator for resolution of fibrin clots after glaucoma filtering procedures. Am J Ophthalmol. 1991;111:247-248.
4. Richards DW. Intracameral tissue plasminogen activator to treat blocked glaucoma implants. Ophthalmic Surg. 1993;24:854-855.
5. Moon JI, Chung SK, Myong YW, Chung SM, Baek NH, Rhee SW. Treatment of postcataract fibrinous membranes with tissue plasminogen activator. Ophthalmology. 1992;99:1256-1259.
6. Lesser GR, Osher RH, Whipple D, Abrams GW, Cionni RJ. Treatment of anterior chamber fibrin following cataract surgery with tissue plasminogen activator. J Cataract Refract Surg. 1993;19:301-305.
7. Tomy S, Lawrence H, Kristin SH, Marouf LM, Yee RW. Low-dose intraocular tissue plasminogen activator treatment for traumatic total hyphema, postcataract, and penetrating keratoplasty fibrinous membranes. J Cataract Refract Surg. 1995;21:219-224.
8. Peyman GA, Nelson NC Jr, Alturki W, et al. Tissue plasminogen activating factor assisted removal of subretinal hemorrhage. Ophthalmic Surg. 1991;22: 575-582.
9. Vander JF. Tissue plasminogen activator irrigation to facilitate removal of subretinal hemorrhage during vitrectomy. Ophthalmic Surg. 1992;23:361-363.
10. Lambrou FH, Snyder RW, Williams GA. Use of tissue plasminogen activator in experimental hyphema. Arch Ophthalmol. 1987;105:995-997.
11. Williams DF, Han DP, Abrams GW. Rebleeding in experimental traumatic hyphema treated with tissue plasminogen activator. Arch Ophthalmol. 1990;108: 264-266.
12. Lattikainen L, Mattila J. The use of tissue plasminogen activator in post-traumatic total hyphaema. Graefes Arch Clin Exp Ophthalmol. 1996;234:67-68.
13. Jaffe GJ, Green GDJ, Abrams GW. Stability of recombinant tissue plasminogen activator. Am J Ophthalmol. 1989;108:90-91.
14. Ward C, Week S. Dilution and storage of recombinant tissue plasminogen activator (Activase) in balanced salt solutions. Am J Ophthalmol. 1990;109:98-99.
15. Wilson FM. Traumatic hyphema: pathogenesis and management. Ophthalmology. 1980;87:910-919.
16. Liedman SD, Pollen A, Podos SM. Treatment of experimental hyphema with intraocular fibrinolytic agents. Arch Ophthalmol. 1962;68:72-78.
17. Friedman MW. Streptokinase in ophthalmology. Am J Ophthalmol. 1952;35:1184-1187.
18. Cherfan GM, Maghraby AK, Tabbara KF, Nasr Y, Hassan H. Dissolution of intraocular fibrinous exudate by streptokinase. Ophthalmology. 1991;98:870-874.
19. Leet DM. Treatment of total hyphema with urokinase. Am J Ophthalmol. 1977;84:870-874.
20. Williams GA, Hatchell DL, Collier D, et al. Clearance from the anterior chamber of RBCs from human diabetes. Arch Ophthalmol. 1984;102:930-931.
21. Dabbs CK, Aaberg TM, Aguilar HE, Sternberg P, Meredith TA. Complications of tissue plasminogen activator. Am J Ophthalmol. 1990;110:354-360.
22. Sternberg P, Aguilar HE, Carolyn D, Aaberg TM. The effect of tissue plasminogen activator on retinal bleeding. Arch Ophthalmol. 1990;108:720-722.